Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02997254 · ClinicalTrials.gov registry record

COMparison of Physiological Algorithms for Real-time Evaluation of Atrial Fibrillation

A clinical trial of Atrial Fibrillation and Abnormal Heart Rhythms, sponsored by Stanford University.

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT02997254 is a study of Atrial Fibrillation and Abnormal Heart Rhythms that is actively recruiting participants, run by Stanford University. The registered enrollment target is 1,000 participants, below the 2,992-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02997254, a study of Atrial Fibrillation and Abnormal Heart Rhythms, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

This is a cohort study to evaluate algorithms for mapping atrial fibrillation by mapping atrial structure and mapping electrical activity to detect physiologically important areas. A key innovation of the observation study is to assess tracking of physiological activity in AF, in relation to tissue activity (MAP recordings), and in relation to AF waves of activity. This observational work extends prior studies that focused on focal and rotational activity, dispersion of electrical activity, low voltage activity and others.

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2016-12-01
Est. Completion 2027-06-30

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT02997254

The ClinicalTrials.gov registry entry for NCT02997254 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,992-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (67% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 0 interventions.

NCT02997254 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02997254 about?

NCT02997254 is a clinical study titled "COMparison of Physiological Algorithms for Real-time Evaluation of Atrial Fibrillation". This is a cohort study to evaluate algorithms for mapping atrial fibrillation by mapping atrial structure and mapping electrical activity to detect physiologically important areas. A key innovation of the observation study is to assess tracking of physiological activity in AF, in relation to tissue...

What is the current status of trial NCT02997254?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2016-12-01. Estimated completion is 2027-06-30.

What conditions does trial NCT02997254 study?

This clinical trial studies the following conditions: Atrial Fibrillation, Abnormal Heart Rhythms.

Who is sponsoring clinical trial NCT02997254?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02997254 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.